Sutro Biopharma, Inc.

NASDAQ:STRO

Biotechnology

Healthcare
$8.72 +1.13%

+$0.32 today

Market cap
$144.76M
Beta
1.55
P/E (TTM)
-0.0
EPS (TTM)
-$1,174.12
52W Low $6.70High $43.85

Volume 0.24M

Average 0.28M

Balance Sheet

Inspect the capital base behind the business.

Assets

$173.83M

FY 2025 · Annual

-55.1% YoY

Liabilities

$306.28M

FY 2025 · Annual

-10.6% YoY

Equity

-$132.45M

FY 2025 · Annual

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents30.41M47.25M69.27M190.3M58.13M
Short-term Investments167.52M287.11M306.35M126.59M83.3M
Net Receivables12.45M7.12M36.08M8.62M3.98M
Inventory00000
Other Current Assets111.67M9.85M17.8M5.52M
Total Current Assets218.52M353.15M421.54M343.31M150.93M
Property, Plant & Equipment (Net)51.59M51.06M44.76M35.87M21.55M
Goodwill00000
Intangible Assets00000
Long-term Investments68.78M(32.02M)000
Tax Assets00000
Other Non-current Assets2.53M34.75M4.44M8.03M1.35M
Total Non-current Assets122.89M53.79M49.19M43.9M22.9M
Total Assets341.41M406.94M470.74M387.21M173.83M
Account Payables6.01M4.8M9.44M10.48M7.57M
Short-term Debt9.38M17.09M4.06M00
Tax Payables0015.17M18K0
Deferred Revenue5.5M16.76M20.67M69.78M10.56M
Other Current Liabilities11.42M11.64M18.58M16.91M17.56M
Total Current Liabilities41.74M66.55M93.75M131.89M75.13M
Long-term Debt15.74M3.77M000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)089.89M202.49M193.35M221.56M
Other Non-current Liabilities146K119K1.69M1.69M1.69M
Total Non-current Liabilities47.11M123.35M227.34M210.71M231.15M
Total Liabilities88.84M189.9M321.09M342.61M306.28M
Common Stock46K58K61K83K9K
Retained Earnings(333.41M)(452.62M)(559.41M)(786.87M)(977.96M)
Accumulated OCI(314K)(618K)21K39K19K
Other Stockholders Equity00000
Minority Interest00000
Total Equity252.56M217.05M149.65M44.6M(132.45M)
Total Debt57.37M55.02M33.64M23.15M15.67M
Net Debt26.96M7.76M(35.63M)(167.15M)(42.46M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$73.7M
Short-term Investments$128.9M
Receivables$12.5M
Other Current$5.9M
Total Current Assets$221.0M
PP&E (Net)$19.1M
Other Non-current$1.9M
Total Non-current Assets$21.0M
Total Assets$242.0M

Analysis

Selected assets total $242.0M for Latest. The largest visible component is Short-term Investments at $128.9M, about 53.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
SC 13GSC 13G filingNov 9, 2026
4Statement of changes in beneficial ownershipSep 22, 2026
SC 13G/ASC 13G/A filingAug 14, 2026

How much cash does STRO have?

Sutro Biopharma, Inc. (STRO) reported $58.13M in cash and equivalents in fiscal 2025.

How much debt does STRO carry?

Sutro Biopharma, Inc. (STRO) reported $15.67M of total debt, with net debt of -$42.46M.